Skip to main content

Advertisement

SpringerLink
Log in

Predictive value of bone marrow accumulation of Tc-99m tetrofosmin for subsequent development of distant metastases in breast cancer

  • ORIGINAL ARTICLE
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Objective

We evaluated the predictive value of bone marrow accumulation of technetium (Tc)-99m tetrofosmin in patients with breast cancer for distant metastases in comparison with conventional prognostic factors such as clinical stage, tumor size, axillary lymph node (Node) status, and estrogen receptor (ER) status.

Methods

Bone marrow scans with Tc-99m tetrofosmin were performed on 64 patients with breast cancer who had no clinical evidence of distant metastases. Accumulation in the femoral marrow was classified into four patterns, no detectable, lower, higher, and intensively higher. Higher or intensively higher pattern was interpreted as abnormal. Thirty-six patients with abnormal accumulation (marrow-positive group) and 28 patients without abnormal accumulation (marrow-negative group) were enrolled in the follow-up study. The mean length of observation after scans was approximately 3 years. The predictive value of femoral marrow status and conventional prognostic factors for distant metastases was evaluated by statistical analysis.

Results

Univariate analysis showed a significantly higher incidence of subsequent bone metastases (36% > 4%; P < 0.005), and distant metastases (69% > 18%; P < 0.001) in the marrow-positive group when compared with the marrow-negative group. Conventional prognostic factors except tumor size were also significantly associated with the development of distant metastases; 77% in clinical stage 3 > 39% in clinical stages 1, 2, P < 0.05; 64% in Node-positive >29% in Node-negative, P < 0.01; and 70% in ER negative >27% in ER positive, P < 0.005. These conventional factors were not significantly associated with bone metastases. The Cox proportional hazard ratio for bone metastases was markedly higher in femoral marrow status (hazard ratio = 11.07). The distant metastases-free survival was significantly reduced in ER negative (P < 0.0005), Node-positive (P = 0.0215), and clinical stage 3 patients (P = 0.0163). On the other hand, a more marked difference was observed in the femoral marrow status (P < 0.0001). The hazard ratio for distant metastases was 2.44 in clinical stage, 2.74 in tumor size, 2.74 in Node, and 3.68 in ER, which were each independent prognostic factors associated with distant metastases. However, femoral marrow status was markedly associated with distant metastases (hazard ratio = 5.27).

Conclusions

Bone marrow accumulation of Tc-99m tetrofosmin can be a promising prognostic factor independent of conventional prognostic factors for predicting development of not only bone metastases but also distant metastases in breast cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. IJ Diel (2001) ArticleTitleBone marrow staging for breast cancer: is it better than axillary node dissection? Semin Oncol 28 236–44 Occurrence Handle11402433 Occurrence Handle10.1016/S0093-7754(01)90116-2 Occurrence Handle1:STN:280:DC%2BD3MzjsVCgtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  2. KW Jauch NM Heiss U Gruetzner (1996) ArticleTitlePrognostic significance of bone marrow micrometastases inpatients with gastric cancer J Clin Oncol 14 1810–7 Occurrence Handle8656249 Occurrence Handle1:STN:280:DyaK283ktlOguw%3D%3D

    PubMed  CAS  Google Scholar 

  3. F Lindemann G Schlimok P Dirschedl (1992) ArticleTitlePrognostic significance of micrometastatic tumor cells in bone marrow of colorectal cancer patients Lancet 340 685–9 Occurrence Handle1381801 Occurrence Handle10.1016/0140-6736(92)92230-D Occurrence Handle1:STN:280:DyaK38zpsFyqug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  4. K Pantel J Izbicki B Passlick (1996) ArticleTitleFrequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small cell lung cancer without overt metastases Lancet 347 649–53 Occurrence Handle8596379 Occurrence Handle10.1016/S0140-6736(96)91203-9 Occurrence Handle1:STN:280:DyaK287nsF2jsg%3D%3D

    Article  PubMed  CAS  Google Scholar 

  5. S Braun K Pantel P Muller (2000) ArticleTitleCytokeratin-positive cells in the bone marrow and survival of patients with stage 1, 2, or 3 breast cancer N Engl J Med 342 525–33 Occurrence Handle10684910 Occurrence Handle10.1056/NEJM200002243420801 Occurrence Handle1:STN:280:DC%2BD3c7jt1ejsw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  6. F Hepp C Kentenich W Janni (2000) ArticleTitleHematogeneous micrometastases detected in bone marrow of patients with stage FIGO 1–2 carcinoma of the uterine cervix predicts poor prognosis Proc Am Assoc Cancer Res 41 2488–93

    Google Scholar 

  7. WJ Janni F Hepp C Kentenich (2000) ArticleTitlePrognostic significance of disseminated tumor cells in bone marrow of patients with primarily diagnosed ovarian cancer (Abstract 1517) Proc Am Soc Clin Oncol 19 383a

    Google Scholar 

  8. S Wakasugi A Noguchi T Katuda (2002) ArticleTitlePotential of 99mTc-MIBI for detecting bone marrow metastases J Nucl Med 43 596–602 Occurrence Handle11994520

    PubMed  Google Scholar 

  9. S Wakasugi K Ohta Y Hasegawa (2001) ArticleTitleDetection of minimal residual disease in acute leukemia by 99mTc-MIBI femoral marrow imaging Clin Nucl Med 26 325–30 Occurrence Handle11290893 Occurrence Handle10.1097/00003072-200104000-00009 Occurrence Handle1:STN:280:DC%2BD3MrgsVGgtw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  10. LH Sobin ID Fleming (1997) ArticleTitleTNM classification of malignant tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer Cancer 80 1803–4 Occurrence Handle9351551 Occurrence Handle10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9 Occurrence Handle1:STN:280:DyaK1c%2FhtF2itA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  11. W Janni D Rjosk S Braun (2000) ArticleTitleClinical relevance of occult metastatic cells in the bone marrow of patients with different stages of breast cancer Clin Breast Cancer 1 217–25 Occurrence Handle11899646 Occurrence Handle1:STN:280:DC%2BD387mvValtw%3D%3D Occurrence Handle10.3816/CBC.2000.n.018

    Article  PubMed  CAS  Google Scholar 

  12. VT DeVita SuffixJr (1989) ArticleTitleBreast cancer therapy: exercising all our opinions N Engl J Med 320 527–9 Occurrence Handle10.1056/NEJM198902233200812

    Article  Google Scholar 

  13. M Overgaard PS Hansen J Overgaad (1997) ArticleTitlePostoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy N Engl J Med 337 949–55 Occurrence Handle9395428 Occurrence Handle10.1056/NEJM199710023371401 Occurrence Handle1:STN:280:DyaK2svktFSitA%3D%3D

    Article  PubMed  CAS  Google Scholar 

  14. J Ragaz SM Jackson N Le (1997) ArticleTitleAdjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer N Engl J Med 337 956–62 Occurrence Handle9309100 Occurrence Handle10.1056/NEJM199710023371402 Occurrence Handle1:STN:280:DyaK2svktFSitQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  15. S Menard R Bufalino F Rilke N Cascinelli U Veronesi MI Colnaghi (1994) ArticleTitlePrognosis based on primary breast carcinoma instead of pathological nodal status Br J Cancer 70 709–12 Occurrence Handle7917924 Occurrence Handle1:STN:280:DyaK2M%2FgtFelsQ%3D%3D

    PubMed  CAS  Google Scholar 

  16. K Pantel RH Brakenhoff (2004) ArticleTitleDissecting the metastatic cascade Nat Rev Cancer 4 448–56 Occurrence Handle15170447 Occurrence Handle10.1038/nrc1370 Occurrence Handle1:CAS:528:DC%2BD2cXksVaisbY%3D

    Article  PubMed  CAS  Google Scholar 

  17. S Braun FD Vogl B Naume W Janni MP Osborne C Coombes et al. (2005) ArticleTitleA pooled analysis of bone marrow micrometastasis in breast cancer N Engl J Med 353 793–802 Occurrence Handle16120859 Occurrence Handle10.1056/NEJMoa050434 Occurrence Handle1:CAS:528:DC%2BD2MXovVKlu7s%3D

    Article  PubMed  CAS  Google Scholar 

  18. JL Mansi U Berger T Mcdonnell (1989) ArticleTitleThe fate of bone marrow micrometastases in patients with primary breast cancer J Clin Oncol 7 445–9 Occurrence Handle2926469 Occurrence Handle1:STN:280:DyaL1M7nslChtA%3D%3D

    PubMed  CAS  Google Scholar 

  19. N Harbeck M Untch L Pache (1994) ArticleTitleTumor cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up Br J Cancer 69 566–71 Occurrence Handle7510120 Occurrence Handle1:STN:280:DyaK2c7mvV2luw%3D%3D

    PubMed  CAS  Google Scholar 

  20. G Gebauer T Fehm E Merkle (2001) ArticleTitleEpithelial cells in bone marrow of breast cancer patients at time of primary surgery: clinical outcome during long-term follow-up J Clin Oncol 19 3669–74 Occurrence Handle11504748 Occurrence Handle1:STN:280:DC%2BD3MvlvV2rsg%3D%3D

    PubMed  CAS  Google Scholar 

  21. L Mileshkin R Blum JF Seymour (2004) ArticleTitleA comparison of fluorine-18 fluoro-deoxyglucose PET and technetium-99m sestamibi in assessing patients with multiple myeloma Eur J Haematol 72 32–7 Occurrence Handle14962260 Occurrence Handle10.1046/j.0902-4441.2004.00177.x Occurrence Handle1:STN:280:DC%2BD2c%2FntlKmtQ%3D%3D

    Article  PubMed  CAS  Google Scholar 

  22. W Janni S Gastroph F Hepp (2000) ArticleTitlePrognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma Cancer 88 2252–9 Occurrence Handle10820346 Occurrence Handle10.1002/(SICI)1097-0142(20000515)88:10<2252::AID-CNCR8>3.0.CO;2-Q Occurrence Handle1:STN:280:DC%2BD3c3otlSgug%3D%3D

    Article  PubMed  CAS  Google Scholar 

  23. K Pantel M von Knebel Doeberitz JR Izbicki (1997) ArticleTitleDisseminated tumor cells: diagnosis, prognostic relevance, phenotyping and therapeutic strategies Chirurg 68 1241–50 Occurrence Handle9483347 Occurrence Handle10.1007/s001040050351 Occurrence Handle1:STN:280:DyaK1c7ksVensw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  24. HM Abdel-Dayem J Sanchez S Al-Mohannadi (1992) ArticleTitleDiffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor J Nucl Med 33 2014–8 Occurrence Handle1279140 Occurrence Handle1:STN:280:DyaK3s%2FlslylsQ%3D%3D

    PubMed  CAS  Google Scholar 

  25. BD Fletcher JE Wall SL Hanna (1993) ArticleTitleEffect of hematopoietic growth factors on MR images of bone marrow in children undergoing chemotherapy Radiology 189 745–50 Occurrence Handle7694312 Occurrence Handle1:STN:280:DyaK2c%2Flt1KjsA%3D%3D

    PubMed  CAS  Google Scholar 

  26. Y Sugawara SJ Fisher KR Zasadny (1998) ArticleTitlePreclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy J Clin Oncol 16 173–8 Occurrence Handle9440740 Occurrence Handle1:CAS:528:DyaK1cXmtlOksQ%3D%3D

    PubMed  CAS  Google Scholar 

  27. WJ Yao CK Hoh RA Hawkins (1995) ArticleTitleQuantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines J Nucl Med 36 794–800 Occurrence Handle7738650 Occurrence Handle1:STN:280:DyaK2M3ls12ksA%3D%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, Osaka, 537-8511, Japan

    Shigetoshi Wakasugi, Terumi Hashizume, Atsushi Noguchi & Takeshi Ohnishi

  2. Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

    Hideaki Tsukuma

  3. Department of Breast Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan

    Hideo Inaji

Authors
  1. Shigetoshi Wakasugi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hideaki Tsukuma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hideo Inaji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Terumi Hashizume
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Atsushi Noguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Takeshi Ohnishi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shigetoshi Wakasugi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wakasugi, S., Tsukuma, H., Inaji, H. et al. Predictive value of bone marrow accumulation of Tc-99m tetrofosmin for subsequent development of distant metastases in breast cancer. Ann Nucl Med 21, 429–437 (2007). https://doi.org/10.1007/s12149-007-0047-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-007-0047-6

Key words

Search

Navigation